Trust Company of Vermont’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $83.9K | Sell |
124
-32
| -21% | -$21.8K | ﹤0.01% | 477 |
|
|
2025
Q3 | $99.7K | Buy |
156
+15
| +11% | +$9.11K | ﹤0.01% | 447 |
|
|
2025
Q2 | $75.6K | Sell |
141
-17
| -11% | -$8.13K | ﹤0.01% | 486 |
|
|
2025
Q1 | $66.4K | Hold |
158
| – | – | ﹤0.01% | 478 |
|
|
2024
Q4 | $65.3K | Sell |
158
-4
| -2% | -$1.75K | ﹤0.01% | 492 |
|
|
2024
Q3 | $81.8K | Buy |
162
+14
| +9% | +$6.8K | ﹤0.01% | 437 |
|
|
2024
Q2 | $72.1K | Hold |
148
| – | – | ﹤0.01% | 444 |
|
|
2024
Q1 | $79.9K | Sell |
148
-4
| -3% | -$2.19K | ﹤0.01% | 416 |
|
|
2023
Q4 | $84.4K | Buy |
152
+2
| +1% | +$939 | 0.01% | 370 |
|
|
2023
Q3 | $65.6K | Sell |
150
-63
| -30% | -$31.4K | ﹤0.01% | 421 |
|
|
2023
Q2 | $107K | Hold |
213
| – | – | 0.01% | 382 |
|
|
2023
Q1 | $107K | Sell |
213
-14
| -6% | -$6.7K | 0.01% | 385 |
|
|
2022
Q4 | $92.6K | Buy |
227
+14
| +7% | +$5.43K | 0.01% | 394 |
|
|
2022
Q3 | $69K | Hold |
213
| – | – | 0.01% | 438 |
|
|
2022
Q2 | $75K | Buy |
+213
| New | +$86.9K | 0.01% | 422 |
|
|
2022
Q1 | – | Sell |
-230
| Closed | -$151K | – | 515 |
|
|
2021
Q4 | $151K | Buy |
+230
| New | +$144K | 0.01% | 346 |
|
|
2021
Q3 | – | Sell |
-230
| Closed | -$145K | – | 500 |
|
|
2021
Q2 | $145K | Sell |
230
-28
| -11% | -$15.5K | 0.01% | 346 |
|
|
2021
Q1 | $126K | Buy |
258
+8
| +3% | +$4.01K | 0.01% | 353 |
|
|
2020
Q4 | $125K | Hold |
250
| – | – | 0.01% | 343 |
|
|
2020
Q3 | $98K | Hold |
250
| – | – | 0.01% | 356 |
|
|
2020
Q2 | $83K | Sell |
250
-7,635
| -97% | -$2.21M | 0.01% | 377 |
|
|
2020
Q1 | $1.91M | Sell |
7,885
-1,891
| -19% | -$493K | 0.18% | 108 |
|
|
2019
Q4 | $2.55M | Hold |
9,776
| – | – | 0.19% | 108 |
|
|
2019
Q3 | $2.66M | Buy |
9,776
+9,365
| +2,279% | +$2.61M | 0.21% | 108 |
|
|
2019
Q2 | $113K | Hold |
411
| – | – | 0.01% | 383 |
|
|
2019
Q1 | $92K | Buy |
411
+11
| +3% | +$2.27K | 0.01% | 407 |
|
|
2018
Q4 | $74K | Hold |
400
| – | – | 0.01% | 417 |
|
|
2018
Q3 | $100K | Hold |
400
| – | – | 0.01% | 413 |
|
|
2018
Q2 | $87K | Hold |
400
| – | – | 0.01% | 431 |
|
|
2018
Q1 | $77K | Sell |
400
-23
| -5% | -$4.25K | 0.01% | 428 |
|
|
2017
Q4 | $66K | Hold |
423
| – | – | 0.01% | 457 |
|
|
2017
Q3 | $66K | Hold |
423
| – | – | 0.01% | 453 |
|
|
2017
Q2 | $68K | Buy |
423
+23
| +6% | +$3.73K | 0.01% | 458 |
|
|
2017
Q1 | $62K | Sell |
400
-50
| -11% | -$6.89K | 0.01% | 454 |
|
|
2016
Q4 | $53K | Hold |
450
| – | – | 0.01% | 472 |
|
|
2016
Q3 | $51K | Hold |
450
| – | – | 0.01% | 426 |
|
|
2016
Q2 | $42K | Hold |
450
| – | – | 0.01% | 406 |
|
|
2016
Q1 | $35K | Hold |
450
| – | – | ﹤0.01% | 435 |
|
|
2015
Q4 | $33K | Hold |
450
| – | – | ﹤0.01% | 450 |
|
|
2015
Q3 | $33K | Hold |
450
| – | – | 0.01% | 451 |
|
|
2015
Q2 | $29K | Buy |
450
+150
| +50% | +$10.4K | ﹤0.01% | 487 |
|
|
2015
Q1 | $23K | Hold |
300
| – | – | ﹤0.01% | 525 |
|
|
2014
Q4 | $22K | Hold |
300
| – | – | ﹤0.01% | 532 |
|
|
2014
Q3 | $18K | Hold |
300
| – | – | ﹤0.01% | 564 |
|
|
2014
Q2 | $20K | Hold |
300
| – | – | ﹤0.01% | 521 |
|
|
2014
Q1 | $18K | Hold |
300
| – | – | ﹤0.01% | 530 |
|
|
2013
Q4 | $16K | Hold |
300
| – | – | ﹤0.01% | 521 |
|
|
2013
Q3 | $15K | Hold |
300
| – | – | ﹤0.01% | 511 |
|
|
2013
Q2 | $13K | Buy |
+300
| New | +$13.1K | ﹤0.01% | 539 |
|
Other funds holding IDXX
JSC
Trust Company of Vermont's IDXX Position: Q4 2025 in Review
Trust Company of Vermont reduced its Idexx Laboratories (IDXX) stake by 21% in Q4 2025, selling an estimated $21.8K and leaving 124 shares worth $83.9K. The position accounts for ﹤0.01% of the portfolio, ranked #477.
Trust Company of Vermont first reported a position in IDXX in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.66M in Q3 2019. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.
- Trust Company of Vermont held 124 shares of Idexx Laboratories worth $83.9K as of Q4 2025.
- Trust Company of Vermont sold 32 Idexx Laboratories shares in Q4 2025, an estimated $21.8K.
- Idexx Laboratories made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #477 holding.
- Trust Company of Vermont first reported a position in Idexx Laboratories in Q2 2013 and has held it in 49 quarters since.
- Trust Company of Vermont's Idexx Laboratories position peaked at $2.66M in Q3 2019.
- 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.